Rosalie Luiten studied Biomedical Sciences and obtained her PhD degree at the University of Leiden in 1998 in collaboration with the pharmaceutical company Centocor Inc., Malvern PA, USA. Rosalie has an extensive international track record in vitiligo research, tumor immunology and immunotherapy of melanoma. She acquired this expertise as Marie Curie postdoctoral fellow at the Ludwig Institute for Cancer Research in Brussels, followed by postdoc research at the Netherlands
Cancer Institute (NKI-AVL) in Amsterdam and the Leiden University Medical Center.
She is inventor of 4 patent applications. In 2004, she obtained the prestigious NWO-VIDI grant for Innovational Research, and established her independent research group at the AMC of the University of Amsterdam.
Since 2008, she is Head of the Laboratory of Experimental Dermatology of Amsterdam UMC and in 2014 she was appointed as full professor of Experimental Dermatology at the University of Amsterdam. Rosalie has a keen interest in applying research in the clinic, thereby generating the valuable “bridge” between laboratory and clinic, to achieve innovation in medicine. She has acquired specific knowledge on entrepreneurship in life sciences. Her team MICure to develop innovative immunotherapy for melanoma won the NGI Venture Challenge 2012 and the Amsterdam Innovation Award as runner up.
Rosalie is Head of the Pigment cell research team that joins forces of both
preclinical and clinical researchers, at the Dermatology department of Amsterdam UMC.
Rosalie Luiten is Chair of Pigmentfonds Nederland, Program Leader Cancer Immunology of the Amsterdam Institute for Infection and Immunity.